Biolase inc.

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2023, and to answer questions. To access the live call, dial 1-877-545-0523 (U.S.) or +1 973-528-0016 (International) and provide the following code: 180082.

Biolase inc. Things To Know About Biolase inc.

BIOLASE Technology, Inc. (BIOLASE), a dental devices company, has promoted its chief financial officer (CFO) David M. Mulder to the company as new chief executive officer (CEO), effective March 5, 2009. Mulder succeeds Jake St. Philip, who has resigned his positions as CEO and director of the company to pursue other interests. …BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2023, and to answer questions. To access the live call, dial 1-866-682-6100 (U.S.) or +1 862-298-0702 (International) and ask to join the BIOLASE call.LAKE FOREST, Calif., July 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2022 financial and operating results on Thursday, August 11, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day …BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2022, and to answer questions. To access the ...BIOLASE Inc (BIOL). NASDAQ. Valores en USD. Aviso legal.

700 µs. Tip Diameter. 200 – 1200 µm. The first Waterlase iPlus debuted in February 2012. Since then, the technology has been updated, refined and enhanced on numerous occasions to ensure the best experience for dentist and patient alike. Dimensions. 11 x 19 x 33 in (28 x 48 x 84cm) Weight. 75 lbs. (34 kg) BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…IRVINE, Calif., Nov. 13, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has entered into a $12.5 million senior secured term loan agreement with SWK Funding LLC. SWK Funding LLC is a subsidiary of SWK Holdings Corporation, a Dallas, Texas-based healthcare focused investment firm.

FOOTHILL RANCH, Calif., Nov. 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2021 financial and operating results on Wednesday, November 10, 2021 after the close of the U.S. financial markets and will host a conference call and webcast that …Nov 7, 2023 · LAKE FOREST, Calif., Nov. 7, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and ...

BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…Dental Laser Procedures & Treatments. BIOLASE award-winning all-tissue and soft-tissue dental lasers are used for minimally invasive procedures and treatments including Endodontics, Periodontics, Dental Implants, Restorative Dentistry, Soft Tissue, and more. Dentists & Laser Dentistry. Hygienists.Jul 26, 2023 · BIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT. LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ) ("BIOLASE" or the "Company"), a global leader in dental lasers ... BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and full year ended December 31, 2022, and to answer questions. To access the live call, dial 1-888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following code: 121864.

Dec 4, 2023 · Biolase Inc (NASDAQ:BIOL)’s Major holders. Investors are also buoyed by the number of investors in a company, with Biolase Inc having a total of N/A institutions that hold shares in the company. The top two institutional holders are Walleye Capital LLC with over 14205.0 shares worth more than $0.1 million.

All SEC Filings. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2023, and to answer questions. To access the live call, dial 1-866-682-6100 (U.S.) or +1 862-298-0702 (International) and ask to join the BIOLASE call.Feb 27, 2023 · LAKE FOREST, Calif., Feb. 27, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers and a company continually focused on improving the dental ecosystem, has ... Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023.BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit is $26.00 , which reflects the issuance of the Series H Convertible Preferred Stock with an original issue discount.Charts. Forms. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit was $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount.

BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023. BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the close of the U.S. financial markets and will host a conference call and …BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…Nov 10, 2022 · BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2022, and to answer questions. To access the live call, dial 1-888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following code: 720380. BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive …BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. , a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000...

Mattel Inc.’s slogan is “The World’s Mattel.” The corporation clearly expresses that its mission is to make a difference in a global scale through effectively serving children in need.BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a ...700 µs. Tip Diameter. 200 – 1200 µm. The first Waterlase iPlus debuted in February 2012. Since then, the technology has been updated, refined and enhanced on numerous occasions to ensure the best experience for dentist and patient alike. Dimensions. 11 x 19 x 33 in (28 x 48 x 84cm) Weight. 75 lbs. (34 kg)The industry leading webinar series adds new dates and content for multi-specialty support. LAKE FOREST, Calif., June 21, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today the extension of its digital learning webinar series "Advancing Dentistry" for remote dental training and …Biolase Mucocele Removal Protocol. Follow. from BIOLASE, Inc. 2 years ago — via Parallel Uploader. Recommended; Description; Comments.700 µs. Tip Diameter. 200 – 1200 µm. The first Waterlase iPlus debuted in February 2012. Since then, the technology has been updated, refined and enhanced on numerous occasions to ensure the best experience for dentist and patient alike. Dimensions. 11 x 19 x 33 in (28 x 48 x 84cm) Weight. 75 lbs. (34 kg)Dentists & Laser Dentistry. BIOLASE dental laser technology is designed expressly for dental applications, such as cavity preparations, soft tissue surgeries, and much more. Learn why Waterlase is the essential dental laser solution for your practice. LEARN MORE. Includes Net Income, Adjustments, and Cash flows from investig & financing activities. View Cash Flow. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….Global Leader in Dental Lasers. BIOLASE is the world’s leading innovator in dental lasers. Our state-of-the-art dental lasers deliver unparalleled precision, efficiency, and patient comfort with minimally invasive solutions for optimal outcomes.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the...

FOOTHILL RANCH, Calif., Jan. 26, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced unaudited preliminary revenue results for its fourth quarter ended December 31, 2020. The Company also announced its current cash position of approximately $25 million, providing it with the …

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada ...Biolase India Private Limited, established in 2011, is engaged in the Healthcare sector in Mumbai. Explore their Corporate Structure, Financials, and More.FOOTHILL RANCH, Calif., Jan. 10, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced preliminary 2021 fourth quarter revenue results that are ...BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit is $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount.About BIOLASE, Inc. BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers; products that are focused on …Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued.Biolase Inc (NASDAQ:BIOL)’s Major holders. Investors are also buoyed by the number of investors in a company, with Biolase Inc having a total of N/A institutions that hold shares in the company. The top two institutional holders are Walleye Capital LLC with over 14205.0 shares worth more than $0.1 million.Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Biolase, Inc. Enters into the Eleventh Amendment to Credit Agreement with SWK Funding LLC CI Nov. 09: BIOLASE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CIBIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for ...Filter stock price historical data by date with the ability to view Opens, Highs, Lows, Closes, VWAPs, Volume % Change, Change, Trade Value and Trades. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to ...BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2023, and to answer questions. To access the live call, dial 1-877-545-0523 (U.S.) or +1 973-528-0016 (International) and provide the following code: 180082.LAKE FOREST, Calif., June 28, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a single institutional investor to purchase approximately $6.5 million of its common stock and pre-funded warrants in a registered …Instagram:https://instagram. steel war penniesopening time for us stock markethow to mine shiba inuhow much is a penny worth in copper value BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada is ...Shortly following the special meeting, the Board of Directors exercised such discretion to effect a 1-for-100 reverse stock split that will become effective at 11:59 p.m. Eastern Time on July 27, 2023, and the Company's common stock will begin trading on a split-adjusted basis at the opening of the market on July 28, 2023. ibkr fx tradingtriple witch BIOLASE, Inc. (NASDAQ:BIOL) issued its quarterly earnings data on Thursday, November, 9th. The medical technology company reported ($3.89) EPS for the quarter. The medical technology company earned $10.92 million during the quarter. BIOLASE had a negative trailing twelve-month return on equity of 503.34% and a negative net margin of 50.61%.LAKE FOREST, Calif., Feb. 27, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers and a company continually focused on improving the dental ecosystem, has ... ashton kutcher investment app LAKE FOREST, Calif., May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a ...BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software.